Feature|Videos|November 26, 2024
KinetiSol® Technology: Disrupting the Solid Amorphous Dispersion Landscape
Author(s)Austin Px
Elizabeth Hickman (Chief Business Officer, AustinPx) explains the company's approach to improving bioavailability, highlighting KinetiSol technology.
Elizabeth Hickman joined Pharmaceutical Technology to provide an overview of AustinPx, the company's bioavailability offerings, and KinetiSol technology, which represents a major breakthrough in amorphous dispersions. Learn more about:
- How AustinPx was created and the strategy behind taking a technology company and turning it into a CDMO;
- The origin of KinetiSol and how it can provide a faster, broader, and greener technology for amorphous solid dispersions;
- How KinetiSol can alleviate challenges associated with spray drying.
Related Content
Trending on Pharmaceutical Technology
1
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
2
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5